Interim update on the use of targeted therapy in acute lymphoblastic leukaemia - ESMO | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
ESMO
2023
·
Europe
·
Oncology
Interim update on the use of targeted therapy in acute lymphoblastic leukaemia
Document
Analyser ce document